Invest in intelligence that delivers

Contact

Spherix Offering

Stay ahead of the curve and uncover emerging healthcare trends to strengthen your strategy & tactics.

Capitalize on commercially relevant market insights across the lifecycle.

Our strategic advisory services combine robust, independent market data and deep expertise to deliver unparalleled commercial value.

Independent, continuous intelligence that tracks how specialty markets evolve — across clinical, commercial, and market access dimensions.

Our continuous market intelligence provides an unbiased view of the landscape within rapidly evolving specialty markets, including quarterly market trending and a fresh infusion of event-driven and variable content with each wave of research.

Understand the prescriber’s perspective of the competitive landscape.

RealTime Dynamix™ delivers robust, unbiased brand and class trending of KPIs.

  • See the market from the prescriber’s point of view
  • Market trending, core rotational content, and event-driven & variable content with each wave, exploring:
    • Brand use, intentions, promotional activity
    • Disease awareness, controversy
    • Pipeline product perceptions

Methodology:

  • Insights based on data from an online surveys of respondents recruited from the Spherix Network, a proprietary group of screened practicing specialty physicians.

Sample Size & Frequency:

Reveal the ‘why’ behind treatment decisions and understand the patient journey.

Patient Chart Dynamix™ audits help you develop patient profiles and uncover opportunities.

  • Capture data not available in claims by tapping into rigorous analysis of large-scale patient chart audits
  • Understand differences between stated and actual treatment patterns with specialists’ attitudinal & demographic data
  • See how clinical trial populations compare to real patient management patterns and identify secondary endpoints that will allow for differentiation

Methodology:

  • Insights are based on patient-level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with rationale for treatment choices.

Sample Size & Frequency:

Uncover the patient’s voice throughout their disease and treatment journey.

Patient Voice Dynamix™ audits help you understand patient experiences and their perceptions. 

  • The patient perspective on unmet needs and the attributes most desired in emerging therapies
  • Differences between patient and physician views on disease severity, treatment priorities, and satisfaction
  • How patient experiences and expectations evolve across the treatment continuum

Methodology:

  • Insights are based on analyses of qualitative interviews and quantitative data collected through online surveys of patients directly recruited via specialists and leading patient advocacy groups, ensuring valid, credible, and representative responses.

Sample Size & Frequency:

Sample sizes vary based on indication and inclusion criteria

Independently assess launches and benchmark history of analogs.

Monthly KPI benchmarking of newly launched products (first 18 months), augmented by 6 quarterly deep dives, including qualitative interviews, focusing on:

  • Drivers and barriers of uptake
  • Promotional activity
  • Patient types gravitating to the launch brand
  • Competitive analyses


Methodology:

  • Insights are based on analyses of quantitative data from an online survey of physicians recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents.


Sample Size & Frequency:

Gain an unbiased perspective of the market and its potential.

Market Dynamix™ reports blend data from specialists and leading KOLs.

  • Market size and current treatment approaches
  • What is needed to support early adoption and optimization of an asset
  • Unmet needs and attributes most desired in new therapeutics
  • Expert opinions on the likely disruption introduced by pipeline agents

Methodology:

  • Insights are based on analyses of quantitative data from an online survey of specialists, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs.


Sample Size & Frequency:

Identify best practices to build high-performing national and regional account teams and benchmark your performance against competitors

Account Management Dynamix™ evaluates the effectiveness of national and regional account teams through the eyes of medical and pharmacy directors at leading health plans and within integrated delivery networks (IDNs).

  • Benchmark account team performance versus competitors across key competencies, resources, and relationship-driving attributes, with separate reporting from medical directors and pharmacy directors
  • Identify key trends and best practices that distinguish high-performing account teams, highlighting the skills, behaviors, and support that strengthen partnerships

Methodology:

Insights are based on complex analysis of quantitative data collected from both payer and IDN medical directors and pharmacy directors, supplemented by qualitative interviews to provide context on what drives strong account relationships.

Sample Size & Frequency

Health Plans

Pharmacy Director Benchmarking

(n=40 with 10 interviews)

Medical Director Benchmarking

(n=40 with 10 interviews)

Annual Summary Report

Understand and predict market access trends and policy shifts affecting formulary management and reimbursement across commercial and government channels.

Benefit Design Dynamix™ explores how commercial and government payers are evolving benefit design structures, formulary placement decisions, and reimbursement strategies, and anticipate drug access trends in the future.

  • Key trends shaping pharmacy and medical benefit management across payers
  • Evolving benefit design and access dynamics
  • Policy and regulatory shifts affecting coverage, reimbursement, and access controls across programs

Methodology:

Insights are informed by quantitative data from online surveys of key medical and pharmacy decision makers at commercial and government payers, as well as providers and employers, all recruited from the Spherix Network. Findings are supplemented by qualitative interviews with a subset of survey respondents.

Sample Size & Frequency:

Quarterly

Quantitative n=50+

Qualitative n=6-8 interviews

Gain strategic account intelligence on leading national and regional payers, IDNs, and specialty pharmacy accounts to support prioritization, engagement strategy, and planning

Key Account Dynamix™ provides structured intelligence on how leading payer, integrated delivery network (IDN), and specialty pharmacy accounts are evolving, enabling manufacturers to compare customers, identify strategic differences, and plan more effective engagement.

  • Comparative assessments that benchmark leading national payers, Blues and regional plans, IDNs, and specialty pharmacies to identify trends, segment differences, and strategic leaders across key dimensions.
  • Detailed account profiles that provide deep, account specific insight to support national and regional account planning, training, and day-to-day engagement.

Methodology:

Insights are based on analyses of quantitative data from online surveys of payer, IDN, and specialty pharmacy decision makers recruited from the Spherix Network, supplemented by qualitative interviews with a subset of survey respondents.

Account profiles are continuously updated using Spherix’s independent market intelligence.

and account-level stakeholder inputs.

Sample Size & Frequency:

Comparative Assessment

Quarterly

Leading Payers

Quant n=30, Qual n=6

Blues and Regional Plans

Quant n=20, Qual n=6

Integrated Delivery Networks

Quant n=20, Qual n=6

Specialty Pharmacies

Quant n=10, Qual n=3

Account Profiles

Continuously Updated

Leading Accounts: 19 profiles

Blues and Regional Plans: 40 profiles

Integrated Delivery Networks: 50 profiles

Specialty Pharmacies: 17 profiles

Uncover best practices and comparative intelligence on indication and brand-level patient service programs and competencies.

Patient Services Dynamix™ provides structured intelligence on how patient service programs are experienced across physicians, office staff, patients, and caregivers, enabling manufacturers to evaluate program performance, identify gaps, and optimize support strategies.

  • Competitive benchmarking of patient service programs versus key competitors
  • Strategic assessments of program strengths, weaknesses, and unmet needs across stakeholders
  • Best practices and program design learnings to support best-in-class patient services development

Methodology:

Insights are based on analyses of quantitative data from online surveys of physicians, office staff, and patients recruited from the Spherix Network, supplemented by qualitative interviews with a subset of survey respondents.

Sample Size & Frequency:

Twice a Year

Quant  n=100-175 physicians, n=100-175 office staff, n=100-175 patients

Qual n= 6-8 physicians

Add context to trending topics and gauge the impact of disruptive events.

Special Topix™ reports on trending events and topics of interest in specialty markets.

  • Gain an objective perspective and context into the real issues influencing market shifts
  • Understand the prescriber’s perspective on trending topics and disruptive events
  • Gather insights on initial and potential lasting impacts on existing commercial brands
  • Deep dive into the mindset of fellows & residents

Methodology:

  • Insights are based on data from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size & Frequency:

  • Report cadence and deliverable depend upon current event/topic being evaluated.

Take advantage of the complete Spherix offering.

Spherix clients have exclusive access to…

Fortify your strategy and tactics with our industry experts who are well-versed in your situation and well-equipped to deliver strategic advisory services across the product lifecycle.

Gain context and insight into the dynamics both in and out of your market basket.

Our unparalleled market intelligence provides a broad and unbiased view of the landscape within rapidly evolving specialty markets, helping you to uncover emerging healthcare trends and strengthen your strategy & tactics.
Gain a competitive edge with insights from the extensive Spherix Healthcare Community, spanning providers, payers, and patients. Our direct relationships with leading KOLs, specialty physicians who meet rigorous quality criteria, payer decision-makers, and real-world patients deliver a 360-degree view of clinical decision-making, access dynamics, and patient experience.

Interactive on-site or virtual sessions with Spherix experts, highlighting commercially relevant analyses, contextual data, and custom insights and advisory services tailored to your business.

Thought partners at your fingertips: Our experts are always just a click or call away, plugged into the ever-evolving landscape, ready to provide an unbiased view, insightfully answer real-time questions, highlight opportunities, and identify disruptors.

Subscribed clients get access to our studies 3+ business days before public release.

Clients have access to the Spherix Analytics & Insights team to perform any ad hoc analyses and customized views of the research.

Spherix analysts and network team can match your targeted call list against our research participants, providing teams the validation that our surveys are reaching your targets.

Clients can add personalized and proprietary insights to their reports by adding one to two client-private questions into surveys – providing a customized take on the market.


Visit our portal to see the full spectrum of what Spherix has to offer. Clients can easily search and find all subscribed data and insights from the past 12 months.

We deliver commercial value by combining independent primary research and customized strategic insights.

Our team of specialty experts analyze independent syndicated datasets through the lens of your distinct situation, providing tailored considerations and contextual data that fuel decision-making.
Sign up for alerts, market insights and exclusive content in your inbox.